Showing results (71-80 of 121) with videos related to

Sort By:
Pageof 13
Academic Radiology|July 2, 2017
"Rounding" the Size of Pulmonary Nodules: Impact of Rounding Methods on Nodule Management, as Defined by the 2017 Fleischner Society GuidelinesBenedikt H Heidinger, Ursula Nemec, Kevin R Anderson, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 4, 2017
Lung Adenocarcinoma Manifesting as Pure Ground-Glass Nodules: Correlating CT Size, Volume, Density, and Roundness with Histopathologic Invasion and SizeBenedikt H Heidinger, Kevin R Anderson, Ursula Nemec, et al.
Translational Lung Cancer Research|June 15, 2026
Lung cancer with EGFR PACC mutations: a practical review of available treatment options and novel therapies on the horizonJulia M Berg, Hollis Viray, Jenna Green, et al.
Cancer Cytopathology|February 4, 2020
Preoperative bronchial cytology for the assessment of tumor spread through air spaces in lung adenocarcinoma resection specimensMayra A Medina, Allison M Onken, Constance de Margerie-Mellon, et al.
Academic Radiology|March 4, 2017
Size Measurement and T-staging of Lung Adenocarcinomas Manifesting as Solid Nodules ≤30 mm on CT: Radiology-Pathology CorrelationBenedikt H Heidinger, Kevin R Anderson, Eoin M Moriarty, et al.
The Annals of Thoracic Surgery|September 21, 2021
Pilot Gene Expression and Histopathologic Analysis of Tracheal Resections in TracheobronchomalaciaRani Singh, Barbara Vidal, Juan Ascanio, et al.
Lung Cancer (Amsterdam, Netherlands)|January 22, 2016
Responses to the multitargeted MET/ALK/ROS1 inhibitor crizotinib and co-occurring mutations in lung adenocarcinomas with MET amplification or MET exon 14 skipping mutationSusan E Jorge, Sol Schulman, Jason A Freed, et al.
Academic Radiology|November 17, 2019
Growth Assessment of Pulmonary Adenocarcinomas Manifesting as Subsolid Nodules on CT: Comparison of Diameter-Based and Volume MeasurementsConstance de Margerie-Mellon, Ritu R Gill, Antonio C Monteiro Filho, et al.
Cancers|March 28, 2024
A Real-World Study of Patient Characteristics and Clinical Outcomes in EGFR Mutated Lung Cancer Treated with First-Line Osimertinib: Expanding the FLAURA Trial Results into Routine Clinical PracticeHollis Viray, Andrew J Piper-Vallillo, Page Widick, et al.
Annals of the American Thoracic Society|September 25, 2025
Endobronchial Ultrasound Guided Sampling: Diagnostic Yield of Needle Biopsy and Cryobiopsy in Addition to Needle AspirationJason Beattie, Hamad Nasim, Jacqueline Chen, et al.
Pageof 13